These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23621932)
41. The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada. Lima VD; Brumme ZL; Brumme C; Sereda P; Krajden M; Wong J; Guillemi SA; Henry B; Hogg RS; Barrios R; Montaner JSG; Curr HIV/AIDS Rep; 2020 Apr; 17(2):77-87. PubMed ID: 32124189 [TBL] [Abstract][Full Text] [Related]
42. Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups. Ogbuagu O; Bruce RD Curr HIV/AIDS Rep; 2014 Dec; 11(4):505-12. PubMed ID: 25342571 [TBL] [Abstract][Full Text] [Related]
43. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. Cohen MS; Muessig KE; Smith MK; Powers KA; Kashuba AD AIDS; 2012 Aug; 26(13):1585-98. PubMed ID: 22507927 [TBL] [Abstract][Full Text] [Related]
44. [Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control]. Jamal LF; Moherdaui F Rev Saude Publica; 2007 Sep; 41 Suppl 1():104-10. PubMed ID: 18038097 [TBL] [Abstract][Full Text] [Related]
45. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. Folkers GK; Fauci AS JAMA; 2010 Jul; 304(3):350-1. PubMed ID: 20639573 [No Abstract] [Full Text] [Related]
46. Message from Toronto--deliver AIDS treatment and prevention. Steinbrook R N Engl J Med; 2006 Sep; 355(11):1081-4. PubMed ID: 16971713 [No Abstract] [Full Text] [Related]
47. Further escalation of the global HIV/AIDS epidemic in 2005 but one million patients on antiretroviral therapy. Gupta RK Euro Surveill; 2005 Nov; 10(11):E051124.2. PubMed ID: 16794285 [TBL] [Abstract][Full Text] [Related]
48. Perspectives on HIV prevention: priorities for a new era. Warren MJ; Bass ES J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2():S255-9. PubMed ID: 23764644 [TBL] [Abstract][Full Text] [Related]
49. Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance. Afassinou K; Chirove F; Govinder KS Math Biosci; 2017 Mar; 285():92-101. PubMed ID: 28095307 [TBL] [Abstract][Full Text] [Related]
50. Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment. Nelson AG; Zhang X; Ganapathi U; Szekely Z; Flexner CW; Owen A; Sinko PJ J Control Release; 2015 Dec; 219():669-680. PubMed ID: 26315816 [TBL] [Abstract][Full Text] [Related]
51. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study. Fowler N; Arkell P; Abouyannis M; James C; Roberts L J Int AIDS Soc; 2014; 17(4 Suppl 3):19563. PubMed ID: 25394070 [TBL] [Abstract][Full Text] [Related]
52. [HIV infection : Reaching a zero risk of transmission]. Henrard S; Wyndham-Thomas C; Van Vooren JP; Goffard JC Rev Med Brux; 2016; 37(4):315-321. PubMed ID: 28525231 [TBL] [Abstract][Full Text] [Related]
53. The AIDS pandemic in historic perspective. Kazanjian P J Hist Med Allied Sci; 2014 Jul; 69(3):351-82. PubMed ID: 23090980 [TBL] [Abstract][Full Text] [Related]
54. Merging care and prevention: preventive properties of antiretroviral drugs and HIV chronification in the case of Switzerland. Genre N; Panese F Anthropol Med; 2022 Mar; 29(1):14-28. PubMed ID: 34544292 [TBL] [Abstract][Full Text] [Related]
55. Contextualising the paediatric HIV epidemic: a review. Eley BS; Tindyebwa D; Kayita J; Kieffer MP; Nduati R; Mwansambo C; Musoke P; Ntumwesigye N; Kinkasa C; Mbori-Ngacha D East Afr Med J; 2006 Dec; 83(12):684-8. PubMed ID: 17685215 [TBL] [Abstract][Full Text] [Related]
56. Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. Chen I; Clarke W; Ou SS; Marzinke MA; Breaud A; Emel LM; Wang J; Hughes JP; Richardson P; Haley DF; Lucas J; Rompalo A; Justman JE; Hodder SL; Eshleman SH PLoS One; 2015; 10(10):e0140074. PubMed ID: 26445283 [TBL] [Abstract][Full Text] [Related]
57. [Application of different death evaluation indicators for HIV/AIDS prevention and treatment]. Zeng L; Ma Y Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):745-8. PubMed ID: 27188376 [TBL] [Abstract][Full Text] [Related]
58. Thirty years of the human immunodeficiency virus epidemic and beyond. Younai FS Int J Oral Sci; 2013 Dec; 5(4):191-9. PubMed ID: 24136672 [TBL] [Abstract][Full Text] [Related]
59. Evaluating the impact of antiretroviral therapy on HIV transmission. Salomon JA; Hogan DR AIDS; 2008 Jul; 22 Suppl 1():S149-59. PubMed ID: 18664947 [TBL] [Abstract][Full Text] [Related]
60. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. Cohen MS; Hellmann N; Levy JA; DeCock K; Lange J J Clin Invest; 2008 Apr; 118(4):1244-54. PubMed ID: 18382737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]